Funded Health Care Startups in Cleveland
Among the 10 most recent health care rounds listed for Cleveland, the largest disclosed amount is Enspire DBS Therapy’s $18M (2023-08-01), which stands out…
Among the 10 most recent health care rounds listed for Cleveland, the largest disclosed amount is Enspire DBS Therapy’s $18M (2023-08-01), which stands out against the rest: only one other disclosed round reaches $5M (Biohm Technologies $5M on 2025-04-02), while several entries cluster at $3M or below (e.g., Coologics $3M on 2025-04-23; Cleveland Clinic $3M on 2023-02-21; The MetroHealth System $3M on 2022-10-12). Stage labeling is also concentrated in classification gaps: 5 of 10 rows are “Series Unknown” (Checkpoint Surgical 2024-06-13 $4M; BIOHM 2023-12-01 $1M; Cleveland Clinic 2023-02-21 $3M; OnShift 2022-06-22 undisclosed; KeborMed 2022-05-13 $2M are examples), and the only “undisclosed” amount is OnShift (2022-06-22). Dates span from 2022-05-13 (KeborMed) through 2025-04-23 (Coologics), with multiple rounds landing in spring 2025 (Coologics 2025-04-23 $3M; Biohm Technologies 2025-04-02 $5M; Asclepii 2025-03-21 $500K).
Most recent rounds
10 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Cleveland health care list, and how big is it relative to the rest?
Enspire DBS Therapy’s $18M (2023-08-01) is the clear outlier among disclosed amounts. The next-highest disclosed figure is Biohm Technologies at $5M (2025-04-02), while multiple other entries sit at $3M or below, such as Coologics $3M (2025-04-23) and Asclepii $500K (2025-03-21).
Do recent rounds cluster into a narrow time window?
Yes, spring 2025 shows a three-entry cluster: Asclepii closed 2025-03-21 for $500K, Biohm Technologies closed 2025-04-02 for $5M, and Coologics closed 2025-04-23 for $3M. Outside that window, disclosed rounds also appear in mid-2024 (Checkpoint Surgical 2024-06-13 at $4M).
How often are stages labeled as “Series Unknown” or “undisclosed,” and does that affect comparisons?
5 of 10 rows carry “Series Unknown” labels, including Checkpoint Surgical ($4M on 2024-06-13) and BIOHM ($1M on 2023-12-01). Separately, OnShift is the only row with an “undisclosed” amount (2022-06-22), which limits any full comparison of disclosed deal sizes across all rows.
Are certain stage categories dominant among the disclosed deals?
Beyond the “Series Unknown” set (5/10), the named stages concentrate into two buckets: Seed (Coologics 2025-04-23 at $3M; Asclepii 2025-03-21 at $500K) and Series B (Biohm Technologies 2025-04-02 at $5M; Enspire DBS Therapy 2023-08-01 at $18M). Other labels—Grant (The MetroHealth System $3M on 2022-10-12) and Corporate Round (OnShift 2022-06-22, undisclosed)—appear once each.
Are there any notable size outliers besides the top round?
Yes: Asclepii’s $500K (2025-03-21) is the smallest disclosed amount in the list, materially below the rest of the disclosed figures. On the high end, Enspire DBS Therapy’s $18M (2023-08-01) also dwarfs most other disclosed rounds, including those at $2M (KeborMed 2022-05-13) and $1M (BIOHM 2023-12-01).
Does the list show evidence of a Cleveland-specific geographic concentration versus duplicates or different locations?
All 10 entries specify Cleveland, Ohio, United States, with no alternate cities shown under the Cleveland label. That makes the pattern strongly location-consistent across the time span, from KeborMed (2022-05-13) through Coologics (2025-04-23).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.